---------------------------------
The Pharmacist e-Link™ Continuing Education Center is designed to provide you with expanded online access to the highest quality of continuing education on a complimentary basis, through the convenience of the Velocity™ Online Learning Management System. |
---------------------------------
---------------------------------
Need Help logging into the Pharmacicst e-Link site?
Click Here for Registration and
Login Information
---------------------------------
 |
 |
 Pharmacist e-Link CE Spotlight |
 |
|
...From NCPA's 2006 Annual Convention and Trade Exposition
Medicare Part D - Changes in 2007 That Will Affect Your Community Pharmacy
2006 brought massive changes to community pharmacy with the implementation of Medicare Part D. This insightful session will give you a recap of the major highlights and look into the future of the program in 2007 and what changes the community pharmacist can expect to see as well as how these changes will affect business in the community pharmacy.
Commercial Support Provided by Community Care Rx. |
|
 |
The Safety of COX-2 Pharmacotherapy for Patients in Pain
There are anecdotal reports about the COX-2 inhibitors of improved efficacy over the traditional NSAIDs. This program will help the practitioner identify those patients with specific risk factors, in whom the risks would outweigh potential benefits, and properly educate those for whom COX-2 use is still an option.
This program is supported by an educational grant from Pfizer Inc. |
|
 |
Understanding ADHD Care for Children: HEDIS® and Beyond
Attention-deficit/hyperactivity disorder (ADHD) is one of the more common chronic conditions of childhood. Children with ADHD may experience significant functional problems such as school difficulties, academic underachievement, troublesome relationships with family members and peers, and behavioral problems. To drive care improvement in ADHD and reinforce the use of clinical guidelines and recommendations for disease management to improve patient outcomes and reduce the overall clinical and economic burden, NCQA developed and approved a HEDIS 2006 performance measure that assesses appropriate follow-up care for children prescribed an ADHD medication. First year reports for that measure are now available, and point toward a need for significant improvement.
This program is supported through educational grants from Eli Lilly and Company and McNeil Pediatrics Division of McNeil-PPC, Inc.
|
 |
The Pharmacist's Role in the Medication Therapy Management of Chronic Pain
Managing your patients with chronic pain is critical to ensuring the best patient outcomes. This session will bring you vital information you need to know to give these pharmacy patients the best possible care and greatly improve their quality of life.
This program is supported by an educational grant from Purdue Pharma L.P.
|
 |
The Health Professional's Role in Formulary Management of Medicare Part D Benefits
Pharmacists are confronting many challenges with the new Medicare Prescription Drug Benefit. Among the most time consuming are formulary management, prior authorization requirements, step therapy protocols, and tight formularies. Most Medicare beneficiaries will encounter new formulary requirements, so preparation will be key for pharmacists during their patient's transition to Medicare Part D when they will be in the crucial position of interacting between the plan, prescriber, and patient to lessen any delays in drug coverage.
This program is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
|
 |
Statin Safety - Recommendations for the Primary Care Community
This enduring material is intended for Physicians, Pharmacists, and Nurses and presents the findings and recommendations of the NLA's Statin Safety Task Force related to its study on statin safety.
This activity was supported by an educational grant from AstraZeneca.
|
|
|
